Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2519-2524

  Bektaş Kayhan, Kivanç ^a   Ünür, Meral ^a   Yaylim Eraltan, Ilhan ^a   Ergen, Arzu ^a   Hafiz, Günter ^a   Karadeniz, Ahmet ^a   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

L MYC; Oral squamous cell carcinoma; Polymorphism

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CARCINOMA; ONCOGENE L MYC; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TURKEY (REPUBLIC);

ADULT; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; FEMALE; GENES, MYC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TURKEY;

EID: 69249197877     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ord RA: Types of Oral Cancer. In: Oral Cancer, The Dentist's Role in Diagnosis, Management, Rehabilitation, and Prevention. Ord RA and Blanchaert RH (eds.). Chicago, Quintessence Publishing Co. Inc., pp. 65-77, 2000.
2. Epstein JB: Oral cancer. In: Burket's Oral Medicine Diagnosis and Treatment. Greennberg MS and Glick M (eds.). Ontario, BC Decker Inc., pp. 194-234, 2003.
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108, 2005.
4. Schantz SP, Hsu TC, Ainslie N and Moser RP: Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 62(23): 3313-3315, 1989. (Pubitemid 20012554)
5. Ogden GR and Wight AJ: Aetiology of oral cancer: Alcohol. Br J Oral Maxillofac Surg 36(4): 247-251, 1998.
6. Tominaga S: Major avoidable risk factors of cancer. Cancer Letters 143(suppl): 19-23, 1999.
7. Warnakulasuriya S, Sutherland G and Scully C: Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41(3): 244-260,2005. (Pubitemid 40311753)
8. Yun YH, Jung KW, Bae JM, Ue JS, Shin SA, Min Park S, Yoo T and YuI Huh B: Cigarette smoking and cancer incidence risk in adult men: National Health Insurance Corportion Study. Cancer Det Prev 29(7): 15-24, 2005. (Pubitemid 40283494)
9. Krontiris TG, Dimartino NA, Colb M and Parkinson DR: Unique allelic restriction fragments of human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature 313(6001): 369- 373.1985.
10. Heighway J, Thatcher N, Cerny T and Hasleton PS: Genetic predisposition to human lung cancer. Br J Cancer 53(4): 453- 457.1986.
11. Nau MM, Brooks BJ, Battey J, McBride OW, Bertness V, Hollis GF and Minna JD: L-MYC a new myc-related gene amplified and expressed in human cell lung cancer. Nature 318(6041): 69-73, 1985. (Pubitemid 16230338)
12. Kaye F, Battey J, Nau M, Brooks B, Seifter E, de Greve J, Birrer M, Sausville E and Minna J: Structure and expression of human L-MYC gene reveal a complex pattern of alternative mRNA processing. Mol Cell Biol 5(7): 186-195, 1988. (Pubitemid 18015577)
13. Kakehi Y and Yoshida O: Restriction fragment length polymorphism of the L-MYC gene and susceptibility to metastasis in renal cancer patients. Int J Cancer 43(3): 391-394, 1989. (Pubitemid 19092317)
14. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V and Deo MG: Restriction fragment length polymorphism of the L-MYC gene in oral cancer patients. Br J Cancer 61(4): 530-533, 1990. (Pubitemid 20126328)
15. Ishizaki K, Kato M, Ikenaga M, Honda K, Ozawa K and Toguchida J: Correlation of L-MYC genotypes to metastasis of gastric cancer and breast cancer. J Natl Cancer Inst 82(3): 238-239, 1990. (Pubitemid 20079998)
16. Young J, Buttenshaw R, Butterworth L, Ward M, Searle J, Leggett B and Chenevix-Trench G: Association of the SS genotype of the L-MYC gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene 9(4): 1053-1056, 1994. (Pubitemid 24095013)
17. Shibuta K, Inoue H, Sato K, Matsuyama A, Ueo H, Tanaka Y, Mafiine K, Barnard GF and Mori M: L-MYC restriction fragment length polymorphism in Japanese patients with esophageal cancer. Jpn J Cancer Res 97(2): 199-203, 2000. (Pubitemid 30130750)
18. Kawashima K, Shikama H, Imoto K, Izawa M, Tsuguo N, Obayashi K and Nishimura S: Close correlation between restriction length polymorphism of the L-MYC gene and metastasis of human lung cancer to lymph nodes and other organs. Proc Natl Acad Sei USA 85(7): 2353-2356, 1988. (Pubitemid 24315890)
19. Tamai S, Sugimura H, Caporaso NE, Resau JH, Trump BF, Weston A and Harris CC: Restriction fragment length polymorphism analysis of the L-MYC gene locus in a case- control study of lung cancer. Int J Cancer 46(3): 411-415, 1990. (Pubitemid 20291095)
20. Tefre T, Borresen AL, Aamdal S and Brogger A: Studies of the L-MYC DNA polymorphism and relation to metastasis in Norwegian lung cancer patients. Br J Cancer 67(6): 809-812, 1990. (Pubitemid 20196982)
21. Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF and Harris CC: Determination of the allelic frequencies of an L-MYC and a p53 polymorphism in human lung cancer. Carcinogenesis 15(4): 583-587, 1994. (Pubitemid 24124397)
22. Ikeda I, Ishizaka Y, Ochiai M, Sakai R, Itabashi M, Onda M, Sugimura T and Nagao M: No correlation between L-MYC restriction fragment length polymorphism and malignancy of human colorectal cancers. Jpn J Cancer Res 79(6): 674-676, 1988. (Pubitemid 18182738)
23. Fernandez T, Saranath D, Advani SH, Deo MG and Soman CS: Restriction fragment length polymorphism of the L-MYC oncogene in non-Hodgkin's lymphoma patients from India. Cancer Letters 125(1-2): 165-172, 1998. (Pubitemid 28151924)
24. Chenevix-Trench G, Southall M and Kidson C: Restriction fragment length polymorphism of the L-MYC and MYB in human leukemia and lymphoma in relation to age-selected controls. Br J Cancer 60(6): 872-874, 1989. (Pubitemid 20024178)
25. Miller SA, Dykes DD and Polesky HS: Simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 76(3): 1215-1219, 1988.
26. Llewellyn CD, Linklater K, Bell J, Johnson NW and Warnakulasuriya KAAS: Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol 39(2): 106-114, 2003.
27. Mork J, Moller B and Glattre E: Familial risk in head and neck squamous cell carcinoma diagnosed before the age of 45: a population-based study. Oral Oncol 35(4): 360-367,1999. (Pubitemid 29276969)
28. Engin K and Erisen L (eds.). Bas-Boyun Kanserleri l.baski Nobel Matbaacihk, Istanbul, pp. 897, 2003.
29. Spinola M, Pedotti P, Dragani TA and Taioli E: Meta-analysis suggests association of L-MYC EcoRI polymorphism with cancer prognosis. Clin Cancer Res 70(74): 4769-4775, 2004. (Pubitemid 38955529)
30. Shibuta K, Mori M, Haraguchi M, Yoshikawa K, Ueo H and Akiyoshi T: Association between restriction fragment length polymorphism of the L-MYC gene and susceptibility to gastric cancer: Br J Surg 85(5): 681-684, 1998. (Pubitemid 28247548)
31. İsbir T,Yaylim İ, Arikan S, Kaytan E,KarŞidaǧT, Bayrak S and Çamlica H: Close relation between restriction fragment length polymorphism of the L-MYC gene and susceptibility to gastric cancer. Cancer Detec Prev 26(6): 454-457, 2002. (Pubitemid 36035375)
32. Mironov N, Aguelon AM, Potapova G, Gorbunov O, Klimenkov A and Yamasaki H: L-MYC allele polymorphism and prognosis for metastases in Russian gastric cancer patients. Eur J Cancer 30A(11): 1732, 1994. (Pubitemid 24355500)
33. Chernitsa OI, Togo AV, Shutkin VA, Hanson KP and Imyanitov EN: S allele of the L-MYC gene is associated with metastatic lung cancer in patients from Moldova. Eur J Cancer 34(11): 1816-1817,1998.
34. Dolcetti R, Pelucchi S, Maestro R, Rizzo S, Pastore A and Boiocchi M: Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol 248(5): 279-285, 1991.
35. Togo AV, Suspitsin EN, Grigoriev MY, Ilyushik ES, Karpova MB, Hanson KP and Imyanitov EN: L-MYC polymorphism in cancer patients, healthy blood donors and elderly, tumor-free individuals in Russia. Int J Cancer 85(6): 747-750, 2000.
36. Kumimoto H, Hamajima N, Nishimoto Y, Matsuo K, Shinoda M, Hatooka S and Ishizaki K: L-MYC genotype is associated with different susceptibility to lung cancer in smokers. Jpn J Cancer Res 93(7): 1-5, 2002. (Pubitemid 34144705)
37. Kumimoto H, Hamajima N, Nishizawa K, Nishimoto Y, Matsuo K, Harada H, Shinoda M, Hatooka S and Ishizaki K: Different susceptibility of each L-MYC genotype to esophageal cancer risk factors. Jpn J Cancer Res 92(7): 735-739, 2001. (Pubitemid 32747218)
38. Shih CM, Kuo YY, Wang YC, Jian SL, Hsu YT, Wu HY, Guo MW and Wang YC: Association of the L-MYC polymorphism with lung cancer susceptibility and prognosis in relation to age- selected controls and stratified cases. Lung Cancer 36(2): 125-132, 2002.
39. Kawashima K, Imoto K, Izawa M, Naruke T, Obayashi K, Sawada T, Moriya N, Hojo K, Konda C, Makuuchi M and Nishimura S: Restriction length polymorphism (RFLP) of the L-MYC is related to the progression of human colon and stomach cancers. Proc Jpn Acad 63B: 300-303, 1987.
40. Kawashima K, Nomura S, Hirai H, Fukushi S, Karube T, Takeuchi K, Naruke T and Nishimura S: Correlation of L-MYC RFLP with metastasis prognosis and multiple cancer in lung-cancer patients Int J Cancer 50(4): 557-561, 1992.
41. Presti JC Jr, Hincley J and Reuter VE: L-MYC allelotype in renal cell carcinoma. Cancer Genetics Cytogenetics 88(1): 66-68, 1998.
42. Kakehi Y, Taki Y and Yoshida O. Restriction fragment length polymorphism of the L-MYC gene susceptibility to metastasis in genitourinary cancers. Urol Int 47(suppl 1): 86-89, 1991.
43. Ejarque MJ, Vicente M, Bernues M, Oliver A, Vicente J, Capella G, Lluis F and Chechile G: Restriction fragment length polymorphism of the L-MYC gene is not a prognostic factor in bladder cancer patients. Br J Cancer 79(11-12): 1855-1858, 1999.
44. Yaylim İ, İsbir T, Özẗrk O, Turna A, İşitmangil T, Zonüzi F and Çamlica H: Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human non-small cell lung cancer? Cancer Gen Cytogen 134(2): 118-122, 2002.
45. Kondratieva TV, Imyanitov EN, Togo AV, Zaitseva OA, Yatsuk OS, Romanenko SM, Bersnev VP and Hanson KP: L-MYC and GMSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas. J Exp Clin Cancer Res 79(2): 197-200, 2000.
46. Isbir T, Yaylim İ, Ankan S, Kücücük S and Çamlica H: Increased frequency of the S-allele of the L-MYC oncogene in breast cancer. MoI Med 8(9): 521-524, 2002. (Pubitemid 36332363)